Xarelto® Lawsuits Filed Over Serious Side Effects Including Severe Bleeding, Stroke, and Death
Xarelto, a blood-thinning drug, is used to reduce the risk of blood clots and stroke in patients with atrial fibrillation (“AFib” or irregular heartbeat) as well as for the prevention of serious blood clots in patients who’ve undergone knee or hip replacement surgery.
However, Xarelto can cause irreversible severe bleeding such as:
- Gastrointestinal bleeding
- Kidney bleeding
- Brain hemorrhage
Xarelto use has also been attributed to other serious side effects, including: stroke, heart attack, and even death.
Xarelto lawsuits are on the rise due to the serious irreversible side effects. In fact, adverse bleeding events are outpacing those of its competitors such as Pradaxa® and Eliquis®. The makers of Xarelto state that this product doesn’t require regular blood monitoring and life style changes, but they do not warn consumers of the irreversible nature of the side effects.
Note – Do not change medications without first consulting your doctor.
Xarelto® and the Xarelto logo are marks of Janssen Pharmaceuticals, Inc., licensed from Bayer HealthCare AG.
Pradaxa® is a registered trademark of Boehringer Ingelheim Pharmaceuticals, Inc.
Eliquis® is a registered trademark of the Bristol-Myers Squibb Company.
